26 Nov 2019 Tami Freeman Gallium-68 (68Ga) is a positron emitter that’s becoming established as a valuable diagnostic isotope, primarily for detection of neuroendocrine tumours (NETs). Such tumours do not metabolize glucose well – precluding their visualization via standard FDG-PET […]
15 Nov 2019 David Kramer Two North American companies hope their novel production processes for technetium-99m give them a leg up in an increasingly crowded market. The global supply chain for the world’s most-used radioisotope, the medical imaging tracer technetium-99m, […]
Found and Chief Technology Officer, Dr. Paul Schaffer, of ARTMS Products Inc., Vancouver, British Columbia – October 10, 2019 – Utilizing the ARTMS QUANTM Irradiation System (QISTM) and collaborating with scientists and clinical researchers from the Odense University Hospital (OUH) […]
Charles S. Conroy Chief Executive Officer of ARTMS Products Inc., Vancouver, British Columbia – September 10, 2019 – ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed […]
ARTMS invited presentations in September Vancouver, September 24, 2018 /BusinessWire/ — ARTMS Products, Inc. announced today that it has been invited to present at the National Nuclear Security Administration’s 2018 Mo-99 Topical Meeting on Tuesday, September 25th and the Third International […]
First-in-class, advanced technology enables production of high-value radioisotopes on medical cyclotrons VANCOUVER, August 8, 2018 — ARTMS Products today announced it received CE marking approval for its first-in-class, advanced technology QUANTM Irradiation System TM for producing high-value radioisotopes, such as […]
Vancouver, British Columbia. – December 18, 2017 – Today, ARTMS Products Inc., the leader in the development of novel technologies which enable the production of the world’s most-used diagnostic imaging isotope, announced it has raised US$3 million. The investment comes […]
Today, ARTMS Products, Inc. announced they have signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99TM Irradiation System (QISTM) for radioisotope production. The goal of the partnership is to supply equipment, technologies and research that supports the production […]
ARTMS Products, Inc., a Vancouver-based medical technology company, has won ‘Most Promising Pre-Commercial Technology’ at the BC Tech Technology Impact Awards recently held in Vancouver. Chosen from a very competitive pool of companies from diverse areas of industry, this distinction […]
ARTMS Products, Inc., a Vancouver-based medical technology company, is pleased to announce that it has entered into a strategic partnership with Alliance Medical to enable and demonstrate an alternative, non-reactor supply of technetium-99m (Tc-99m) within the United Kingdom. ARTMS will […]